A. García-palomo

发表

Electronic health records and patient registries in medical oncology departments in Spain

N. Ribelles, C. Jara, J. Chacón, 2021, Clinical and Translational Oncology.

Previously diagnosed cancer and mortality after ST‐segment elevation acute myocardial infarction treated with primary angioplasty

F. Fernández-Vázquez, I. Iglesias-Garriz, C. Garrote, 2020, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Melatonin modulation of intracellular signaling pathways in hepatocarcinoma HepG2 cell line: role of the MT1 receptor

J. González‐Gallego, J. L. Mauriz, S. Carbajo-Pescador, 2011, Journal of Pineal Research.

Biweekly Docetaxel and Vinorelbine in Anthracycline‐Resistant Metastatic Breast Cancer: A Multicenter Phase II Study

P. Diz, G. Martín, C. Rodríguez, 2003, American journal of clinical oncology.

S. Servitja, I. Láng, M. Margelí, 2021, European Journal of Cancer.

Stabilization of Hypoxia-Inducible Factors and BNIP3 Promoter Methylation Contribute to Acquired Sorafenib Resistance in Human Hepatocarcinoma Cells

C. Verslype, J. González‐Gallego, J. L. Mauriz, 2019, Cancers.

Use of non-steroidal anti-inflammatory drugs and risk of breast cancer: The Spanish Multi-Case-control (MCC) study

V. Moreno, M. Kogevinas, A. Tardón, 2016, BMC Cancer.

Experience with eribulin in HR+/HER2- metastatic breast cancer, including a male.

P. Rovira, A. García-palomo, M. J. Molina Garrido, 2018, Future oncology.

Changes in the expression of melatonin receptors induced by melatonin treatment in hepatocarcinoma HepG2 cells

J. González‐Gallego, J. L. Mauriz, S. Carbajo-Pescador, 2009, Journal of pineal research.

FoxO proteins: regulation and molecular targets in liver cancer.

J. González‐Gallego, J. L. Mauriz, S. Carbajo-Pescador, 2014, Current medicinal chemistry.

Inhibition of matrix metalloproteinase‐9 and nuclear factor kappa B contribute to melatonin prevention of motility and invasiveness in HepG2 liver cancer cells

R. Ordoñez, J. González‐Gallego, J. L. Mauriz, 2014, Journal of pineal research.

Methionine Aminopeptidases as Potential Targets for Treatment of Gastrointestinal Cancers and other Tumors

J. González‐Gallego, J. Mauriz, M. Tuñón, 2010 .

Shift work and colorectal cancer risk in the MCC-Spain case-control study.

V. Moreno, M. Kogevinas, A. Tardón, 2017, Scandinavian journal of work, environment & health.

Melatonin enhances sorafenib actions in human hepatocarcinoma cells by inhibiting mTORC1/p70S6K/HIF-1α and hypoxia-mediated mitophagy

J. González‐Gallego, J. L. Mauriz, S. Carbajo-Pescador, 2017, Oncotarget.

Sorafenib resistance in hepatocarcinoma: role of hypoxia-inducible factors

J. González‐Gallego, J. L. Mauriz, A. García-palomo, 2018, Experimental & Molecular Medicine.

Palbociclib in combination with endocrine therapy versus capecitabine in hormonal receptor-positive, human epidermal growth factor 2-negative, aromatase inhibitor-resistant metastatic breast cancer: a phase III randomised controlled trial-PEARL.

A. Guerrero-Zotano, M. Koehler, M. Margelí, 2020, Annals of oncology : official journal of the European Society for Medical Oncology.

Sorafenib resistance in hepatocarcinoma: role of hypoxia-inducible factors

J. González‐Gallego, J. L. Mauriz, A. García-palomo, 2018, Experimental & Molecular Medicine.

Modulation of Autophagy by Sorafenib: Effects on Treatment Response

J. Muntané, R. Ordoñez, J. González‐Gallego, 2016, Front. Pharmacol..

Efficacy of fulvestrant in the treatment of postmenopausal women with endocrine-resistant advanced breast cancer in routine clinical practice

M. Fontanillas, F. Carabantes, J. Illarramendi, 2018, Clinical and Translational Oncology.

Breast cancer management in the elderly

J. Cueva, L. Calvo, S. Antolín, 2014, Clinical and Translational Oncology.

Melatonin Activates Endoplasmic Reticulum Stress and Apoptosis in Rats with Diethylnitrosamine-Induced Hepatocarcinogenesis

R. Ordoñez, J. González‐Gallego, J. L. Mauriz, 2015, PloS one.

Inhibition of VEGF expression through blockade of Hif1α and STAT3 signalling mediates the anti-angiogenic effect of melatonin in HepG2 liver cancer cells

R. Ordoñez, J. González‐Gallego, J. L. Mauriz, 2013, British Journal of Cancer.

A dose-dense schedule of docetaxel followed by doxorubicin and cyclophosphamide as neoadjuvant treatment for breast cancer: results from a phase II study

M. Ramos, L. Calvo, A. González, 2011, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

A phase II study of weekly vinorelbine and trastuzumab in patients with HER2-positive metastatic breast cancer.

J. Mayordomo, M. Ruíz-Borrego, P. Sánchez‐Rovira, 2008, Clinical breast cancer.

Use of non-steroidal anti-inflammatory drugs and risk of breast cancer: The Spanish Multi-Case-control (MCC) study

V. Moreno, M. Kogevinas, A. Tardón, 2016, BMC Cancer.

Broad consensus on the optimal sequence for the systemic treatment of metastatic breast cancer: results from a survey of Spanish medical oncologists

J. Albanell, A. Lluch, A. de Juan, 2019, Journal of drug assessment.

P2.16-43 Immunotherapy in Elderlies. Real World Data

M. Pedraza, A. Rodriguez, A. García-palomo, 2019, Journal of Thoracic Oncology.

Phase II study of dose-dense doxorubicin and docetaxel as neoadjuvant chemotherapy with G-CSF support in patients with large or locally advanced breast cancer

M. Ramos, L. Calvo, J. García-Mata, 2008 .

Suspected Extragonadal Germ-Cell Cancer Syndrome Presenting with an Orbital Mass and Elevation of Serum Cea, CA19-9 and CA50 Levels

G. Martín, A. Dueñas, P. Sánchez, 1995, Tumori.

Changes in the expression of melatonin receptors induced by melatonin treatment in hepatocarcinoma HepG2 cells

J. González‐Gallego, J. L. Mauriz, M. Tuñón, 2009, Journal of pineal research.